A review of 22 articles found a higher incidence of "altered skin sensations" and alopecia in individuals receiving oral semaglutide than in those receiving placebo. The US Food and Drug ...
Welcome to the first in a series of monthly columns intended to keep you up-to-date on what's new at Medscape Gastroenterology. I am hopeful that this column will evolve so as to offer a venue within ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results